ANGO vs EXAS · rev $292.5M vs rev $2.76B
AngioDynamics Inc (ANGO) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ANGO currently screens at market cap $378.5M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ANGO and EXAS stock pages for the full models.
Not investment advice.